Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction

Summary: Glutamine:fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme of the hexosamine biosynthetic pathway (HBP). A 54-bp exon 9 of GFPT1 is specifically included in skeletal and cardiac muscles to generate a long isoform of GFPT1 (GFPT1-L). We showed that SRSF1 and Rbfox1/2 c...

Full description

Bibliographic Details
Main Authors: Paniz Farshadyeganeh, Mohammad Nazim, Ruchen Zhang, Bisei Ohkawara, Kazuki Nakajima, Mohammad Alinoor Rahman, Farhana Nasrin, Mikako Ito, Jun-ichi Takeda, Kenji Ohe, Yuki Miyasaka, Tamio Ohno, Akio Masuda, Kinji Ohno
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223018230
_version_ 1827781734041649152
author Paniz Farshadyeganeh
Mohammad Nazim
Ruchen Zhang
Bisei Ohkawara
Kazuki Nakajima
Mohammad Alinoor Rahman
Farhana Nasrin
Mikako Ito
Jun-ichi Takeda
Kenji Ohe
Yuki Miyasaka
Tamio Ohno
Akio Masuda
Kinji Ohno
author_facet Paniz Farshadyeganeh
Mohammad Nazim
Ruchen Zhang
Bisei Ohkawara
Kazuki Nakajima
Mohammad Alinoor Rahman
Farhana Nasrin
Mikako Ito
Jun-ichi Takeda
Kenji Ohe
Yuki Miyasaka
Tamio Ohno
Akio Masuda
Kinji Ohno
author_sort Paniz Farshadyeganeh
collection DOAJ
description Summary: Glutamine:fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme of the hexosamine biosynthetic pathway (HBP). A 54-bp exon 9 of GFPT1 is specifically included in skeletal and cardiac muscles to generate a long isoform of GFPT1 (GFPT1-L). We showed that SRSF1 and Rbfox1/2 cooperatively enhance, and hnRNP H/F suppresses, the inclusion of human GFPT1 exon 9 by modulating recruitment of U1 snRNP. Knockout (KO) of GFPT1-L in skeletal muscle markedly increased the amounts of GFPT1 and UDP-HexNAc, which subsequently suppressed the glycolytic pathway. Aged KO mice showed impaired insulin-mediated glucose uptake, as well as muscle weakness and fatigue likely due to abnormal formation and maintenance of the neuromuscular junction. Taken together, GFPT1-L is likely to be acquired in evolution in mammalian striated muscles to attenuate the HBP for efficient glycolytic energy production, insulin-mediated glucose uptake, and the formation and maintenance of the neuromuscular junction.
first_indexed 2024-03-11T15:22:58Z
format Article
id doaj.art-3389bd93cb9e4caaa6d1fa76afe19c00
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-11T15:22:58Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-3389bd93cb9e4caaa6d1fa76afe19c002023-10-28T05:08:16ZengElsevieriScience2589-00422023-10-012610107746Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junctionPaniz Farshadyeganeh0Mohammad Nazim1Ruchen Zhang2Bisei Ohkawara3Kazuki Nakajima4Mohammad Alinoor Rahman5Farhana Nasrin6Mikako Ito7Jun-ichi Takeda8Kenji Ohe9Yuki Miyasaka10Tamio Ohno11Akio Masuda12Kinji Ohno13Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USADivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanInstitute for Glyco-core Research (iGCORE), Gifu University, Gifu 501-1193, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Department of Biochemistry and Molecular Biology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR 72205, USADivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Department of Biochemistry and Molecular Biology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR 72205, USADivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, JapanDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya 466-8550, JapanDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Corresponding authorDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Corresponding authorSummary: Glutamine:fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme of the hexosamine biosynthetic pathway (HBP). A 54-bp exon 9 of GFPT1 is specifically included in skeletal and cardiac muscles to generate a long isoform of GFPT1 (GFPT1-L). We showed that SRSF1 and Rbfox1/2 cooperatively enhance, and hnRNP H/F suppresses, the inclusion of human GFPT1 exon 9 by modulating recruitment of U1 snRNP. Knockout (KO) of GFPT1-L in skeletal muscle markedly increased the amounts of GFPT1 and UDP-HexNAc, which subsequently suppressed the glycolytic pathway. Aged KO mice showed impaired insulin-mediated glucose uptake, as well as muscle weakness and fatigue likely due to abnormal formation and maintenance of the neuromuscular junction. Taken together, GFPT1-L is likely to be acquired in evolution in mammalian striated muscles to attenuate the HBP for efficient glycolytic energy production, insulin-mediated glucose uptake, and the formation and maintenance of the neuromuscular junction.http://www.sciencedirect.com/science/article/pii/S2589004223018230Biological sciencesBiochemistryPhysiology
spellingShingle Paniz Farshadyeganeh
Mohammad Nazim
Ruchen Zhang
Bisei Ohkawara
Kazuki Nakajima
Mohammad Alinoor Rahman
Farhana Nasrin
Mikako Ito
Jun-ichi Takeda
Kenji Ohe
Yuki Miyasaka
Tamio Ohno
Akio Masuda
Kinji Ohno
Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
iScience
Biological sciences
Biochemistry
Physiology
title Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
title_full Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
title_fullStr Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
title_full_unstemmed Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
title_short Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
title_sort splicing regulation of gfpt1 muscle specific isoform and its roles in glucose metabolisms and neuromuscular junction
topic Biological sciences
Biochemistry
Physiology
url http://www.sciencedirect.com/science/article/pii/S2589004223018230
work_keys_str_mv AT panizfarshadyeganeh splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT mohammadnazim splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT ruchenzhang splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT biseiohkawara splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT kazukinakajima splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT mohammadalinoorrahman splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT farhananasrin splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT mikakoito splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT junichitakeda splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT kenjiohe splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT yukimiyasaka splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT tamioohno splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT akiomasuda splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction
AT kinjiohno splicingregulationofgfpt1musclespecificisoformanditsrolesinglucosemetabolismsandneuromuscularjunction